IDEX BIOMETRICS ASA: årsregnskap 2024 vs 2023
Shrank 81% on revenue, cash halved-plus
approved 2025-05-21; registry 2025-08-02; journal 2025 617348
Summary
What changed
Comparing Årsregnskap 2024 with 2023 for IDEX BIOMETRICS ASA. Revenue 4.14m NOK → 793.0k NOK (-80.8%). Net result -25.14m NOK → -22.98m NOK. Equity 15.92m NOK → 666.0k NOK.
On the constructive side: operating result improved; net result improved; payroll decreased. Pressures included: revenue fell; equity eroded; cash fell.
Also worth watching: thin equity buffer; sharp cash drawdown; paid-in equity reduced. All figures are taken from the published annual accounts for IDEX BIOMETRICS ASA.
At a glance
Scorecard
What improved
-
↑
Operating result improved
Operating result -25.47m NOK → -24.48m NOK (op. margin -615.5% → -3087.1%). Calculated
-
↑
Net result improved
Net result -25.14m NOK → -22.98m NOK (net margin -607.6% → -2897.4%). Calculated
-
↑
Payroll decreased
Salary cost 2.31m NOK → 1.09m NOK (56% → 137% of revenue). Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 4.14m NOK to 793.0k NOK (-80.8% YoY). Calculated
-
↓
Equity eroded
Book equity 15.92m NOK → 666.0k NOK (equity ratio 47.2% → 5.6%). Calculated
-
↓
Cash fell
Bank deposits 10.82m NOK → 1.92m NOK (-82.2% YoY). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is 5.6% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation
-
·
Sharp cash drawdown
Cash fell by more than 60% YoY (10.82m NOK → 1.92m NOK). Check whether funds moved to group receivables, investments, or operating burn. Interpretation
-
·
Paid-in equity reduced
Paid-in equity fell 52.93m NOK → 39.89m NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
COGS fell
COGS / varekostnad 3.91m NOK → 1.68m NOK (-56.9% YoY). Calculated
-
·
Book investments changed
Investment / intangible book value 1.76m NOK → 459.0k NOK. Reported fact